ATC/DDD

ATC/DDD index H01CB

You are here: Home > ATC/DDD > H > H01 > H01C

- ATC/DDD
Anatomical therapeutic chemical (ATC) classification system
- H
SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
- H01
PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES
- H01C
HYPOTHALAMIC HORMONES

H01CB

Somatostatin and analogues

ATC/DDD code H01CB for Somatostatin and analogues

Somatostatin, octreotide and lanreotide, which are also used in cancer, are classified in this group.

The DDDs of octreotide and lanreotide are based on the treatment of acromegaly.

H01CB01
Somatostatin
H01CB02
Octreotide
H01CB03
Lanreotide
ICD-10
ATC
ICD-10 International Statistical Classification of Diseases and Related Health Problems 10th Revision
ICD-10

ICD-10 is the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD), a medical classification list by the World Health Organization (WHO).

It contains codes for diseases, signs and symptoms, abnormal findings, complaints, social circumstances, and external causes of injury or diseases.

ATC

The Anatomical Therapeutic Chemical (ATC) Classification System is used for the classification of active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.

It is controlled by the World Health Organization Collaborating Centre for Drug Statistics Methodology (WHOCC).

DDD

The defined daily dose (DDD) is a statistical measure of drug consumption, defined by the World Health Organization (WHO).

It is used to standardize the comparison of drug usage between different drugs or between different health care environments.

Home Contact Us